BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38619282)

  • 21. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.
    Graham DB; Cella M; Giurisato E; Fujikawa K; Miletic AV; Kloeppel T; Brim K; Takai T; Shaw AS; Colonna M; Swat W
    J Immunol; 2006 Aug; 177(4):2349-55. PubMed ID: 16887996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory Receptor Crosslinking Quantitatively Dampens Calcium Flux Induced by Activating Receptor Triggering in NK Cells.
    Ganesan S; Höglund P
    Front Immunol; 2018; 9():3173. PubMed ID: 30693005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.
    Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ
    Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
    Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
    Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells.
    Abel AM; Tiwari AA; Gerbec ZJ; Siebert JR; Yang C; Schloemer NJ; Dixon KJ; Thakar MS; Malarkannan S
    Front Immunol; 2018; 9():1168. PubMed ID: 29892299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ly49C Impairs NK Cell Memory in Mouse Cytomegalovirus Infection.
    Forbes CA; Scalzo AA; Degli-Esposti MA; Coudert JD
    J Immunol; 2016 Jul; 197(1):128-40. PubMed ID: 27233959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions.
    Morgado S; Sanchez-Correa B; Casado JG; Duran E; Gayoso I; Labella F; Solana R; Tarazona R
    J Innate Immun; 2011; 3(4):365-73. PubMed ID: 21576932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of ligands for the activating receptor NKG2D.
    Mistry AR; O'Callaghan CA
    Immunology; 2007 Aug; 121(4):439-47. PubMed ID: 17614877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.
    Teng MW; Kershaw MH; Hayakawa Y; Cerutti L; Jane SM; Darcy PK; Smyth MJ
    J Biol Chem; 2005 Nov; 280(46):38235-41. PubMed ID: 16169855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recruitment of activating NK-cell receptors 2B4 and NKG2D to membrane microdomains in mammalian cells is dependent on their transmembrane regions.
    Gütgemann SA; Sandusky MM; Wingert S; Claus M; Watzl C
    Eur J Immunol; 2015 Apr; 45(4):1258-69. PubMed ID: 25545687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells.
    Ryan JC; Naper C; Hayashi S; Daws MR
    Immunol Rev; 2001 Jun; 181():126-37. PubMed ID: 11513134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function.
    Abdool K; Cretney E; Brooks AD; Kelly JM; Swann J; Shanker A; Bere EW; Yokoyama WM; Ortaldo JR; Smyth MJ; Sayers TJ
    J Immunol; 2006 Aug; 177(4):2575-83. PubMed ID: 16888019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa Infection Impairs NKG2D-Dependent NK Cell Cytotoxicity through Regulatory T-Cell Activation.
    Vourc'h M; David G; Gaborit B; Broquet A; Jacqueline C; Chaumette T; Caillon J; Roquilly A; Retiere C; Asehnoune K
    Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32928966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions.
    Wang Z; Guan D; Wang S; Chai LYA; Xu S; Lam KP
    Front Immunol; 2020; 11():202. PubMed ID: 32153568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase.
    Kim HS; Das A; Gross CC; Bryceson YT; Long EO
    Immunity; 2010 Feb; 32(2):175-86. PubMed ID: 20189481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.
    Bryceson YT; Ljunggren HG; Long EO
    Blood; 2009 Sep; 114(13):2657-66. PubMed ID: 19628705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer immunotherapy using a bispecific NK receptor fusion protein that engages both T cells and tumor cells.
    Zhang T; Sentman CL
    Cancer Res; 2011 Mar; 71(6):2066-76. PubMed ID: 21282338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ras activation induces expression of Raet1 family NK receptor ligands.
    Liu XV; Ho SS; Tan JJ; Kamran N; Gasser S
    J Immunol; 2012 Aug; 189(4):1826-34. PubMed ID: 22798674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
    Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
    J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.